we Heart Disease

Heart Disease - Articles, News and Resources on Prevention Coronary Heart Disease Type 2 Diabetes Mellitus

 

Main Prevention Coronary Heart Disease Type 2 Diabetes Mellitus resources

Prevention Coronary Heart Disease Type 2 Diabetes Mellitus

 

Welcome to Heart Disease

 

 

Prevention Coronary Heart Disease Type 2 Diabetes Mellitus News

ACC: Devices May Trump Drugs in Atlanta - MedPage Today


ACC: Devices May Trump Drugs in Atlanta
MedPage Today
Another long-anticipated presentation will bring results from the ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial, which is slated for ...

and more »

Read more...


Glycemic Control in Diabetic ESRD Patients - Renal and Urology News


The Hindu

Glycemic Control in Diabetic ESRD Patients
Renal and Urology News
Whether reaching glycemic goals in type 2 diabetes could prevent cardiovascular events has been addressed in two large randomized double-blind trials in ...
Incidence of CKD increasing in India alonwith Diabetes:ExpertsZee News

all 163 news articles »

Read more...


Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the ... - MarketWatch (press release)


Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the ...
MarketWatch (press release)
The five-year study will follow approximately 12000 patients with type 2 diabetes, who have either a history of previous cardiovascular events or multiple ...
Bristol-Myers, AstraZeneca Commence Saxagliptin Assessment Of Vascular ...RTT News
Bristol-Myers Squibb, AstraZeneca announce postmarketing study for OnglyzaDrug Store News

all 14 news articles »

Read more...


Docs Often Miss Lipid Targets, More So with Women - MedPage Today


Docs Often Miss Lipid Targets, More So with Women
MedPage Today
... of a correct estimate, including a previous myocardial infarction, history of coronary artery disease, and confirmed diagnosis of diabetes mellitus. ...

and more »

Read more...


Human Genome Sciences Announces Fourth-Quarter and Full-Year 2009 Financial ... - MarketWatch (press release)


Human Genome Sciences Announces Fourth-Quarter and Full-Year 2009 Financial ...
MarketWatch (press release)
In the GSK clinical pipeline, darapladib for cardiovascular disease and Syncria(R) for type 2 diabetes are both moving through Phase 3 trials. ...

and more »

Read more...


BMS & AstraZeneca begin phase-4 trial of Saxgliptin in type-2 diabetes with ... - pharmabiz.com


BMS & AstraZeneca begin phase-4 trial of Saxgliptin in type-2 diabetes with ...
pharmabiz.com
The five-year study will follow approximately 12000 patients with type-2 diabetes, who have either a history of previous cardiovascular events or multiple ...

and more »

Read more...


Internet Marketing Club